Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance

被引:13
作者
Wang, Shaochen [1 ,2 ,3 ]
Wu, Congming [1 ]
Shen, Jianzhong [1 ]
Wu, Yongning [1 ,3 ]
Wang, Yang [1 ]
机构
[1] China Agr Univ, Coll Vet Med, Beijing Key Lab Detect Technol Anim Derived Food, Beijing 100094, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Key Lab Chem Safety & Hlth, Beijing, Peoples R China
[3] China Natl Ctr Food Safety Risk Assessment CFSA, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China
基金
“十二五”国家科技支撑计划重点项目”;
关键词
Staphylococcus aureus; Hypermutation; Chronic infection; Bovine subclinical mastitis; Antibiotic resistance; HIGH MUTATION-RATES; PSEUDOMONAS-AERUGINOSA; EVOLUTION; BACTERIA; MUTS; MUTATORS; ACQUISITION; EMERGENCE; GENES;
D O I
10.1016/j.vetmic.2013.04.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hypermutable bacterial strains with greatly elevated spontaneous mutation rates have been described at high frequencies in various clinically important species, particularly in cystic fibrosis (CF) patients. It has been suggested that such strains can play a major role in the development of chronic respiratory infections. Nevertheless, little information is available regarding the potential association between hypermutation and other chronic infection settings. Here, we investigated the mutation frequencies of 261 Staphylococcus aureus isolates from bovine mastitis cases. The comparative analysis revealed that the subclinical mastitis (SM) isolates harbored significantly more hypermutators than the clinical mastitis (CM) isolates (26/141 versus 0/120, P < 0.001, Fisher's exact test). Analysis of mutS and mutL genes, which are major components of the methyl mismatch repair (MMR) system, revealed that 13 of the 14 genetically unrelated hypermutators showed alterations in their deduced MutS and/or MutL amino acid sequences. The hypermutators were much more frequently found to be resistant to all of the 7 antibiotics tested (except sulfafurazole) than the nonmutators. Moreover, the proportion of hypermutators harboring multi-drug resistance was significantly higher than that of the nonmutators as well (P < 0.001). Taken together, this work provides evidence that hypermutability plays an important role in antibiotic resistance development during long-term persistence of S. aureus, and reveals that the link between hypermutation and chronic infections appears not to be restricted to respiratory infections alone. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests
[2]  
approved standard M2-A11, V11th
[3]   The thymidine-dependent small-colony-variant phenotype is associated with hyermutability and antibiotic resistance in clinical Staphylococcus aureus isolates [J].
Besier, Silke ;
Zander, Johannes ;
Kahl, Barbara C. ;
Kraiczy, Peter ;
Brade, Volker ;
Wichelhaus, Thomas A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2183-2189
[4]  
Blázquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810
[5]   The role of mutators in the emergence of antibiotic-resistant bacteria [J].
Chopra, I ;
O'Neill, AJ ;
Miller, K .
DRUG RESISTANCE UPDATES, 2003, 6 (03) :137-145
[6]   Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation [J].
Ciofu, O ;
Riis, B ;
Pressler, T ;
Poulsen, HE ;
Hoiby, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2276-2282
[7]  
Clinical and Laboratory Standards Institute, 2008, M31A3 CLSI
[8]  
COX EC, 1974, GENETICS, V77, P169
[9]   Effect of Mutator P. aeruginosa on Antibiotic Resistance Acquisition and Respiratory Function in Cystic Fibrosis [J].
Ferroni, Agnes ;
Guillemot, Didier ;
Moumile, Kaoutar ;
Bernede, Claire ;
Le Bourgeois, Muriel ;
Waernessyckle, Serge ;
Descamps, Philippe ;
Sermet-Gaudelus, Isabelle ;
Lenoir, Gerard ;
Berche, Patrick ;
Taddei, Francois .
PEDIATRIC PULMONOLOGY, 2009, 44 (08) :820-825
[10]   Mutator bacteria as a risk factor in treatment of infectious diseases [J].
Giraud, A ;
Matic, I ;
Radman, M ;
Fons, M ;
Taddei, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :863-865